Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
PDUFA VII: US FDA Says Money Can’t Solve Meeting Problems
Mar 19 2021
•
By
Derrick Gingery
The FDA said time, not money, is the issue with adding a mid-cycle meeting for prior approval manufacturing supplements. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from Pathways & Standards